• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆细胞因子图谱揭示了 TH2 极化和干扰素在预测 COVID-19 严重程度和生存中的重要性。

Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival.

机构信息

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Modena, Italy.

Infectious Diseases Clinics, Azienda Ospedaliera-Universitaria (AOU) Policlinico and University of Modena and Reggio Emilia, Modena, Italy.

出版信息

Front Immunol. 2022 Mar 21;13:842150. doi: 10.3389/fimmu.2022.842150. eCollection 2022.

DOI:10.3389/fimmu.2022.842150
PMID:35386702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8979161/
Abstract

Although it is now widely accepted that host inflammatory response contributes to COVID-19 immunopathogenesis, the pathways and mechanisms driving disease severity and clinical outcome remain poorly understood. In the effort to identify key soluble mediators that characterize life-threatening COVID-19, we quantified 62 cytokines, chemokines and other factors involved in inflammation and immunity in plasma samples, collected at hospital admission, from 80 hospitalized patients with severe COVID-19 disease who were stratified on the basis of clinical outcome (mechanical ventilation or death by day 28). Our data confirm that age, as well as neutrophilia, lymphocytopenia, procalcitonin, D-dimer and lactate dehydrogenase are strongly associated with the risk of fatal COVID-19. In addition, we found that cytokines related to TH2 regulations (IL-4, IL-13, IL-33), cell metabolism (lep, lep-R) and interferons (IFNα, IFNβ, IFNγ) were also predictive of life-threatening COVID-19.

摘要

虽然现在人们普遍认为宿主炎症反应有助于 COVID-19 的发病机制,但导致疾病严重程度和临床结果的途径和机制仍知之甚少。为了确定能够描述危及生命的 COVID-19 的关键可溶性介质,我们定量检测了入院时采集的 80 名住院 COVID-19 重症患者的血浆样本中的 62 种细胞因子、趋化因子和其他炎症和免疫相关因子,这些患者根据临床结果(第 28 天机械通气或死亡)进行了分层。我们的数据证实,年龄以及中性粒细胞增多、淋巴细胞减少、降钙素原、D-二聚体和乳酸脱氢酶与致命 COVID-19 的风险密切相关。此外,我们还发现与 TH2 调节(IL-4、IL-13、IL-33)、细胞代谢(lep、lep-R)和干扰素(IFNα、IFNβ、IFNγ)相关的细胞因子也可预测危及生命的 COVID-19。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed5/8979161/bf3232d10f84/fimmu-13-842150-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed5/8979161/7d99c32dfbbf/fimmu-13-842150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed5/8979161/13c0e3c5f0fa/fimmu-13-842150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed5/8979161/bf3232d10f84/fimmu-13-842150-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed5/8979161/7d99c32dfbbf/fimmu-13-842150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed5/8979161/13c0e3c5f0fa/fimmu-13-842150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed5/8979161/bf3232d10f84/fimmu-13-842150-g003.jpg

相似文献

1
Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival.血浆细胞因子图谱揭示了 TH2 极化和干扰素在预测 COVID-19 严重程度和生存中的重要性。
Front Immunol. 2022 Mar 21;13:842150. doi: 10.3389/fimmu.2022.842150. eCollection 2022.
2
Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.与秘鲁 COVID-19 住院患者预后较差相关的细胞因子谱。
Front Immunol. 2021 Sep 1;12:700921. doi: 10.3389/fimmu.2021.700921. eCollection 2021.
3
Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.儿童多系统炎症综合征(PIMS-TS)、新冠病毒病(COVID-19)和新冠病毒2型(SARS-CoV2)血清学阳性儿童的血浆生物标志物分析——一项来自印度南部的横断面观察研究
EBioMedicine. 2021 Apr;66:103317. doi: 10.1016/j.ebiom.2021.103317. Epub 2021 Apr 2.
4
Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.趋化因子和类花生酸在严重 COVID-19 患者的肺部引发过度炎症。
J Allergy Clin Immunol. 2021 Aug;148(2):368-380.e3. doi: 10.1016/j.jaci.2021.05.032. Epub 2021 Jun 7.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.干扰素诱导趋化因子水平升高,以及促细胞裂解的 Th1 细胞表型激活,是新冠感染后第二周病情恶化的特征。
Front Immunol. 2020 Oct 20;11:580987. doi: 10.3389/fimmu.2020.580987. eCollection 2020.
7
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.新型冠状病毒-19(SARS-CoV-2)通过白细胞介素-1(IL-1)引起细胞因子风暴导致 COVID-19 的急性重症肺部炎症:一种有前途的抑制策略。
J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6):1971-1975. doi: 10.23812/20-1-E.
8
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.在细胞因子释放综合征背景下 SARS-CoV-2 感染的诊断。
Expert Rev Mol Diagn. 2020 Nov;20(11):1087-1097. doi: 10.1080/14737159.2020.1830760. Epub 2020 Oct 12.
9
Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients.COVID-19 住院患者的 RNA 血症和相关全身细胞因子的时间动力学。
mSphere. 2021 Jun 30;6(3):e0031121. doi: 10.1128/mSphere.00311-21. Epub 2021 May 28.
10
Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19.与 COVID-19 相关的神经精神症状儿童的脑脊液细胞因子、趋化因子和 SARS-CoV-2 抗体特征。
Mult Scler Relat Disord. 2021 Oct;55:103169. doi: 10.1016/j.msard.2021.103169. Epub 2021 Jul 24.

引用本文的文献

1
Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice.追踪 SARS-CoV-2 奥密克戎 BA.1 感染 K18-hACE2 小鼠肺部后炎症消退特征。
PLoS One. 2024 Nov 12;19(11):e0302344. doi: 10.1371/journal.pone.0302344. eCollection 2024.
2
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients.免疫衰老与疫苗效力:通过对多发性硬化症患者 SARS-CoV-2 特异性细胞的免疫代谢分析揭示 **请注意**:以上译文仅供参考,具体内容可根据实际情况进行调整。
Nat Commun. 2024 Mar 29;15(1):2752. doi: 10.1038/s41467-024-47013-0.
3

本文引用的文献

1
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).流式细胞术和细胞分选在免疫学研究中的应用指南(第三版)。
Eur J Immunol. 2021 Dec;51(12):2708-3145. doi: 10.1002/eji.202170126. Epub 2021 Dec 7.
2
Metabolic reprograming shapes neutrophil functions in severe COVID-19.代谢重编程塑造了严重 COVID-19 中性粒细胞的功能。
Eur J Immunol. 2022 Mar;52(3):484-502. doi: 10.1002/eji.202149481. Epub 2021 Dec 24.
3
Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection.
Airway Epithelial-Derived Immune Mediators in COVID-19.
气道上皮衍生免疫介质在 COVID-19 中的作用。
Viruses. 2023 Jul 29;15(8):1655. doi: 10.3390/v15081655.
4
Exploring the Role of CD74 and D-Dopachrome Tautomerase in COVID-19: Insights from Transcriptomic and Serum Analyses.探索CD74和D-多巴色素互变异构酶在COVID-19中的作用:转录组学和血清分析的见解
J Clin Med. 2023 Jul 31;12(15):5037. doi: 10.3390/jcm12155037.
5
Interferons in COVID-19: missed opportunities to prove efficacy in clinical phase III trials?新冠疫情中的干扰素:错失在III期临床试验中证明疗效的机会?
Front Med (Lausanne). 2023 May 30;10:1198576. doi: 10.3389/fmed.2023.1198576. eCollection 2023.
6
Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab.鉴定对托珠单抗治疗有应答的重症 COVID-19 患者的预后免疫标志物。
Front Immunol. 2023 May 5;14:1123807. doi: 10.3389/fimmu.2023.1123807. eCollection 2023.
7
Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.严重 COVID-19 中促炎细胞因子特征的描述。
Front Immunol. 2023 Mar 30;14:1170012. doi: 10.3389/fimmu.2023.1170012. eCollection 2023.
8
Current Status and Future Perspectives of Lactate Dehydrogenase Detection and Medical Implications: A Review.乳酸脱氢酶检测的现状与未来展望及医学意义:综述。
Biosensors (Basel). 2022 Dec 7;12(12):1145. doi: 10.3390/bios12121145.
9
Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections.在最初的武汉原始毒株感染和疫苗突破性德尔塔毒株感染的疾病进展过程中,抗S蛋白IgG亚类的保守纵向变化。
Front Microbiol. 2022 Nov 22;13:1043049. doi: 10.3389/fmicb.2022.1043049. eCollection 2022.
10
Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response.严重 COVID-19 康复患者会产生多功能抗原特异性 CD4+ T 细胞应答。
Int J Mol Sci. 2022 Jul 20;23(14):8004. doi: 10.3390/ijms23148004.
无症状或轻症 SARS-CoV-2 感染孕妇存在炎症的内源性控制。
Nat Commun. 2021 Jul 29;12(1):4677. doi: 10.1038/s41467-021-24940-w.
4
Immunity and inflammatory biomarkers in COVID-19: A systematic review.新型冠状病毒肺炎的免疫和炎症生物标志物:系统评价。
Rev Med Virol. 2021 Jul;31(4):e2199. doi: 10.1002/rmv.2199. Epub 2020 Dec 4.
5
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.单核细胞驱动的非典型细胞因子风暴和异常中性粒细胞激活作为 COVID-19 疾病严重程度的关键介质。
Nat Commun. 2021 Jul 5;12(1):4117. doi: 10.1038/s41467-021-24360-w.
6
COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality.肥胖与 COVID-19 严重程度:瘦素和炎症细胞因子在高发病率和死亡率之间关联中的相互作用。
Front Immunol. 2021 Jun 18;12:649359. doi: 10.3389/fimmu.2021.649359. eCollection 2021.
7
Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19.冠状病毒感染中的细胞死亡:揭示其在 COVID-19 中的作用。
Cells. 2021 Jun 23;10(7):1585. doi: 10.3390/cells10071585.
8
IL-13 is a driver of COVID-19 severity.IL-13 是导致 COVID-19 严重程度的因素之一。
JCI Insight. 2021 Aug 9;6(15):e150107. doi: 10.1172/jci.insight.150107.
9
Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!白细胞介素-6、CXCL10 和浸润巨噬细胞在 COVID-19 相关细胞因子风暴中的作用:不是一荣俱荣,而是众志成城!
Front Immunol. 2021 Apr 26;12:668507. doi: 10.3389/fimmu.2021.668507. eCollection 2021.
10
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity.新冠病毒谜题:解析新疾病实体的病理生理学和表型。
Lancet Respir Med. 2021 Jun;9(6):622-642. doi: 10.1016/S2213-2600(21)00218-6. Epub 2021 May 6.